Detailed View
CORT - Corcept Therapeutics Incorporat
Latest filing: 2026-06-30 | Reporting: gaap
Market Cap
9,291,057,152
Adj EBIT (TTM)
-43,196,000
Enterprise Value
8,982,860,152
Last Price
85.95
Earnings Yield
-0.48%
Return on Capital
-5.88%
Capital
734,900,000
1Y Price Chart
Last Price: $85.95
1Y Change: 20.11%
As of 2026-10-29 | 1Y Change: 20.11%
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-06-30 | 10-Q | 2026 | 256,147,000 | -8,301,000 |
| 2026-03-31 | 10-Q | 2026 | 164,903,000 | -49,601,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 202,125,000 | 4,487,000 |
| 2025-09-30 | 10-Q | 2025 | 207,638,000 | 10,219,000 |
| 2025-06-30 | 10-Q | 2025 | 194,430,000 | 26,675,000 |
| 2025-03-31 | 10-Q | 2025 | 157,214,000 | 3,416,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 181,890,000 | 25,262,000 |
| 2024-09-30 | 10-Q | 2024 | 182,546,000 | 46,598,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.